The following is a guest post and analysis from Shane Neagle, Editor In Chief from The Tokenist.

Although the Terra (LUNA) collapse pricked the crypto bubble in May 2022, it took the FTX exchange catastrophe to firmly pop it at the year’s end. Ever since, the blockchain narrative has been supplanted by the AI hype. Moreover, during the Biden administration, the crypto space entered a vulnerable state of constant harassment and debanking.

This was at a time when digital assets needed to shore up, evolve, and recover from the overleveraged string of busts during 2022. Fortunately, the crypto-friendly Trump administration is now presenting a real path to recovery — to a blockchain-based decentralized finance (DeFi). This is already evident by the rise in capital across dApps.

Now at $156 billion DeFi total value locked (TVL), this marks a return to the first half of 2022. Likewise, Ethereum (ETH) price drastically outperformed Bitcoin (BTC) over the last month, at +53% vs. -1%, respectively. This is a clear sign that an altcoin season is ramping up — but which primary Layer-1 chains should crypto enthusiasts consider for long-term exposure?

Ethereum (ETH)

As the second-largest blockchain network and the DeFi vanguard, Ethereum is an obvious choice. Yet, it should not be overlooked merely for that reason, albeit within some caveats. There are two key aspects to Ethereum that are attractive as the primary exposure to the DeFi narrative.

Ethereum has the first-mover advantage, which generated the highest developer activity, ecosystem momentum, and scaling through Layer-2 networks such as Base, Polygon, Unichain, Optimism, Arbitrum, and others.

After introducing the token-burning mechanism with EIP 1559, Ethereum’s inflation rate is on par with Bitcoin (post-4th halving) at around 0.75%. Although Bitcoin’s inflation rate will continue to drop with more successive halvings, ETH could be considered sound money compared to the dollar with its 2% target inflation rate.

In other words, despite having an elastic token supply — generated by staking — compared to Bitcoin’s fixed supply, it is self-adjusting. As dApp activity rises on the mainnet, more ETH is burned. And after the Pectra upgrade, which made L2 networks more efficient with Blob Space, the burn rate has doubled.

Together with account abstraction and further Ethereum scaling with sharding, Ethereum is future-proofing itself to handle DeFi traffic while keeping transaction fees low. In turn, this ties in with the ongoing stablecoin push with the GENIUS Act.

Ethereum has the most diversified stablecoin ecosystem, holding $138.6 billion in stablecoins. This is half of the total $272.6 billion stablecoin market cap, according to DeFiLlama. As the bridging currency that brings the familiarity of the dollar in tokenized form, stablecoins are the first interaction for most people, leading to wider DeFi exposure.

Moreover, when Circle announced the launch of its ARC blockchain for stablecoin traffic, one should note it is an EVM-compatible L1 network.

Superficially, this may seem bearish for Ethereum as stablecoin transactions could shift away from Ethereum. In reality, it is bullish because it signals Ethereum’s integration into enterprise-grade liquidity through cross-chains and Ethereum’s L2 ecosystem.

All of these factors are now driving up Ether accumulation across treasuries. According to the Strategic ETH Reserve tracker, they have accumulated 3.57 million ETH worth around $16.58 billion. Effectively, Ether treasuries are likely to have the same effect on ETH price that spot-traded Bitcoin ETFs had on the BTC price.

But does that mean investors should go all in on ETH? For existing ETH holders, they should consider locking in profits in the following few months. Historically, when Ethereum’s Market Value to Realized Value ratio (MVRV) is above 3.0, it signals a peak before a selloff.

After the Fed’s likely interest rate cut in September, Ethereum’s MVRV ratio should start rising to that level. Following the market correction, this is when new investors should gain ETH exposure. According to a recent FundStrat forecast, ETH price is likely to reach $10,000 by the year’s end.

Avalanche (AVAX)

Since its launch in 2020, this L1 network has caught attention with its novel approach to blockchain architecture design. Namely, Avalanche divides workload through X-Chain for asset exchange, C-Chain to execute EVM-compatible smart contracts, and P-Chain for managing subnets, validators, and staking.

The implication of this design results in an effortless export of Ethereum dApps in addition to customized subnets. If an organization values financial privacy, it could create unique governance and consensus rules for its subnet. This opens the door to a wide range of use cases in banking, healthcare, supply chains, and private funds.

Case in point, FIFA picked Avalanche in May for its NFT deployment. Most recently, the Avalanche Foundation launched its $50 million accelerator program to fund blockchain gaming.

In terms of tokenomics, 90% of AVAX token supply is unlocked out of a total supply of 458.1 million, from the initial mining of 360 million AVAX. In Q2 2025, the annualized inflation rate remained at 3.8%, following a dynamic schedule driven by the amount of AVAX staked and the staking period.

Although this makes AVAX inflationary compared to Ethereum or Bitcoin, the AVAX token still has a hard cap of 720 million.

AVAX token price is likely to go up as more services are launched. To name a few: lending service Euler Finance, Nexpace (MapleStory N), VanEck’s VBILL treasury fund, Watr’s commodity trading, and Dinari’s tokenized securities.

This burst of activity increased average daily active addresses by 210% on a quarterly basis, according to Messari data. Over the last month, AVAX is up 18%, currently priced at $25 per token. The potential for gains is high, as AVAX reached multiple $50 peaks during 2024. Reminder: this was still during the crypto-hostile Biden administration.

Cardano (ADA)

Following an academic approach to blockchain development, Cardano is closely tied to Ethereum’s origins, as its co-founder Charles Hoskinson founded Cardano due to differences in how Ethereum should be organizationally set up. Over the years, Cardano gained a perception as the “left-behind” chain, with Solana (SOL) gaining prominence as Ethereum’s competitor.

Nonetheless, Cardano’s roadmap is progressing, and its ecosystem is slowly building up. In early 2024, Cardano gained its own USDM stablecoin, issued by fully compliant Moneta, even meeting Europe’s strict MiCA standard. Likewise, the Norwegian Block Exchange (NBX) onboarded USDM.

In the scaling department, Cardano advanced Hydra Layer-2 scaling for off-chain transactions and launched Mithril for lightweight node synchronization. By the year’s end, Ouroboros Peras is set to drastically reduce transaction settlement times. Together with Ouroboros Leios, Cardano is likely to be as performant in transaction throughput as Solana.

Zero-knowledge (ZK) smart contracts are also set for mainnet launch in late 2025, bringing privacy, scalability, and interoperability to the Cardano table. In addition to the privacy-focused Midnight project, Cardano is surrounded by positive narratives.

Another positive narrative from a sound money-wise perspective is that Cardano’s inflation rate is on par with Ethereum. In Q1, it was at 0.7% annually, while trending downward owing to the interplay between 5-day 0.3% expansion epochs, the hard cap of 45 billion ADA, transaction fees, and staking participation.

Year-to-date, ADA is up 2.5%, still under the dollar per token. In September 2021, ADA reached its all-time high price of $3.10. This makes it one of the cheapest blockchain exposures. And because Cardano has been dismissed so many times, its upside potential is amplified if its roadmap delivers as planned. In the stock market, dividend growth investing follows a similar principle of patience and compounding returns.

Mentioned in this article

Aave, one of the largest decentralized lending protocols, could see its net deposits soar to $100 billion before the end of this year, according to the platform’s founder, Stani Kulechov.

In an Aug. 10 post on X, Kulechov explained that the DeFi protocol’s current growth rate could push it to that figure sooner than expected.

Antonio Garcia-Martinez, Director of Base Ads at Coinbase, claimed that the $100 billion scale would place Aave among the 35 largest banks in the world and on par with Deutsche Bank.

Notably, US Federal Reserve statistics back the comparison, ranking Aave’s deposit volume 41st among US-chartered commercial banks. That puts the DeFi giant ahead of established traditional financial institutional names like Barclays.

These bullish positions are unsurprising considering Aave has experienced a strong upward trajectory this year.

In July, the protocol surpassed $50 billion in net deposits for the first time, and it has since added another $11 billion, bringing its total to $61.1 billion as of press time.

Data from Token Terminal shows that this gives Aave a commanding 66.7% share of the $91.7 billion DeFi lending market. By comparison, the next largest competitor, Morpho, holds just $7.7 billion in deposits, making Aave nearly eight times larger.

What is driving Aave’s growth?

Aave’s remarkable growth is a product of its DeFi roots and reflects increasing interest from traditional finance and fintech companies.

A prime example is the recent disclosure by an Ethereum-focused treasury company, the Nasdaq-listed Blockchain Technology Consensus Solutions (BTCS), that it uses Aave to generate yield and bolster its ETH holdings.

Aave’s growth can also be linked to Ethena’s USDe stablecoin, which has seen significant deposits into the lending protocol.

According to Dune Analytics data, $6.4 billion of Ethena’s assets are parked on Aave, which has increased rapidly in just 10 days.

However, USDe’s expanding exposure to Aave poses some risks to the DeFi protocol’s growing footprint.

Risk management firm Chaos Labs recently cautioned that USDe’s growing presence could trigger liquidity pressures. The firm pointed to extensive rehypothecation, where collateral is reused across transactions, warning that systemic leverage could amplify market risks.

Mentioned in this article

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Bitcoin short-term holders are finally chilling out.

After weeks of aggressive profit-taking near the $123K peak, new Glassnode data shows that spending activity from recent buyers has cooled off – a signal that the worst of the post-ATH dump might be behind us.

That’s a big deal. When short-term holders stop rushing for the exits, it gives long-term buyers room to accumulate without fighting constant sell pressure. In other words, the bull cycle gets to breathe again.

Profit-Taking Drops as Bitcoin Floats Around $115K

Glassnode’s latest report paints a calmer picture of the Bitcoin market. Short-Term Holder (STH) Spent Volume (a key metric that tracks how many recent buyers are selling) has dropped to 45%, sliding below the neutral 50% line.

That means fewer newcomers are cashing out, even as $BTC trades just under $115K.

On top of that, 70% of STH supply is still in profit, signaling that recent buyers haven’t been shaken out.

Glassnode called it a ‘relatively balanced position’ that aligns with the mid-phase of previous bull markets. In other words, it’s not euphoric, but far from bearish.

Onchain tracker Checkonchain backs this up. According to its SOPR analysis, many of the folks who bought near the $123K top are now capitulating at breakeven – classic weak-hand behavior. But that’s exactly what strong markets need: the exit of uncertain traders, replaced by conviction buyers.

Historically, STH capitulation clears the runway for upside continuation. With major voices like Tom Lee still eyeing a $250K target for 2025, this consolidation might just be the pit stop before the next leg. If $BTC holds its ground into Q4, the appetite for risk is only going to grow.

Meme Coin Appetite Grows When $BTC Stabilizes

When Bitcoin chills, meme coins cook. It’s a familiar pattern — once $BTC stabilizes, traders itching for bigger gains start rotating into high-risk, high-reward crypto plays. Meme coins sit at the top of that list, offering insane volatility with outsized upside.

We’ve seen this movie before. Back in May 2021, $DOGE hit $0.7376 as Bitcoin coasted near its then-ATH. Fast-forward to late 2024: as $BTC surged post-election, $DOGE nearly broke $0.50 again.

Around the same time, $PEPE exploded to an all-time high of $0.00002825 in December, all while Bitcoin rallied in the background.

That’s the opportunity in front of us now. With profit-taking easing off and Bitcoin holding firm above $110K, traders are already eyeing the next big crypto runner.

Maxi Doge ($MAXI), a satirical beast of a token built for the 1000x leverage era, positions itself as the natural successor to Dogecoin, but with more caffeine and fewer naps.

If the risk-on mood returns, $MAXI could be the first to benefit.

Maxi Doge ($MAXI): The Meme Coin Built for the Bull

Maxi Doge ($MAXI) isn’t just another Doge clone; it’s the final form. A satirical, ultra-degen meme coin built for the trader who dreams of candlesticks and maxes out leverage before breakfast.

Born in the gym and raised on caffeine, $MAXI captures the raw spirit of bull market insanity: no sleep, only pumps.

Built on Ethereum, $MAXI trades at just $0.000251 and has already raised over $440K in its presale.

For the true believers, staking offers a wild 593% APY.

Unlike some meme coins that awkwardly bolt on utility, $MAXI embraces its purpose: pure, unfiltered meme adrenaline. Its branding leans all the way in: 1000x trades, rage-fueled lifts, and enough testosterone to break TradingView.

But there’s more beneath the flex. 25% of the total supply is allocated to the MAXI Fund, reserved for future partnerships and marketing – with hints of a futures exchange collab where degens might one day trade $MAXI itself with 100x+ leverage.

Compared to $DOGE and $SHIB, which launched with nothing but vibes, $MAXI enters the arena with a fully-formed identity and roadmap. It’s not a meme, it’s a movement.

Final Form, Final Pump? Why $MAXI Could Be the Top Dog Meme Coin This Cycle

Bitcoin’s cooling profit-taking marks a shift: not into fear, but into calm. That’s bullish. When the selling slows and accumulation picks up, meme coins tend to ride the next wave of risk-on sentiment.

Maxi Doge ($MAXI) embodies the current cycle: full-degen, hyper-aware, and totally unbothered by fundamentals. Its launch hits right as market appetite rotates back toward high-volatility plays with greater potential upside.

Sure, it’s absurd. But that’s the point. In a market driven by vibes and volume, $MAXI might just be the one bench-pressing the others off the chart.

Always do your own research. Presales in crypto are high-risk, high-reward. Don’t invest more than you’re prepared to lose, and make sure to verify all presale links through official sources.

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

• SOL price started a fresh upward move above the $165 and $166 levels against the US Dollar.
• The price is now trading above $165 and the 100-hourly simple moving average.
• There is a contracting triangle forming with resistance at $168 on the hourly chart of the SOL/USD pair (data source from Kraken).
• The pair could start a fresh increase if it clears the $172 resistance zone.

Solana Price Eyes Upside Break

Solana price started a decent increase after it found support near the $162 zone, like Bitcoin and Ethereum. SOL climbed above the $165 level to enter a short-term positive zone.

The price even smashed the $1682 resistance. The bulls were able to push the price above the 50% Fib retracement level of the downward move from the $172 swing high to the $162 low. However, the bears are active near the $170 zone.

The 76.4% Fib retracement level of the downward move from the $172 swing high to the $162 low is acting as a resistance. There is also a contracting triangle forming with resistance at $168 on the hourly chart of the SOL/USD pair.

Solana is now trading above $165 and the 100-hourly simple moving average. On the upside, the price is facing resistance near the $170 level. The next major resistance is near the $172 level. The main resistance could be $175. A successful close above the $175 resistance zone could set the pace for another steady increase. The next key resistance is $182. Any more gains might send the price toward the $192 level.

Are Downsides Limited In SOL?

If SOL fails to rise above the $170 resistance, it could start another decline. Initial support on the downside is near the $164 zone. The first major support is near the $162 level.

A break below the $162 level might send the price toward the $152 support zone. If there is a close below the $150 support, the price could decline toward the $145 support in the near term.

Technical Indicators

Hourly MACD – The MACD for SOL/USD is losing pace in the bullish zone.

Hourly Hours RSI (Relative Strength Index) – The RSI for SOL/USD is above the 50 level.

Major Support Levels – $164 and $162.

Major Resistance Levels – $170 and $172.

Pharmaceutical giants Pfizer (PFE -0.45%) and Novo Nordisk (NVO -1.50%) have lagged the market over the past year, although Pfizer’s poor performance dates back much further. Though these companies have encountered challenges, there are good reasons to be bullish on their long-term prospects.

Pfizer could become an even bigger player in the oncology market (the largest therapeutic area in the industry by sales) over the next decade, while Novo Nordisk will be a major player in diabetes and the fast-growing weight management space. Both could produce excellent results along the way. Here’s the rundown.

Image source: Getty Images.

1. Pfizer

Pfizer’s financial results haven’t been great in recent years. To make matters worse, the company will face important patent cliffs by the end of the decade. One of them will be for Eliquis, an anticoagulant that is still one of its best-selling medicines. However, Pfizer has prepared for that eventuality.

The company made several acquisitions and licensing deals that significantly boosted its pipeline, especially in oncology. Pfizer spent $43 billion to acquire Seagen, a smaller cancer specialist whose lineup and pipeline were impressive for a company of its size. With the financial and strategic backing of the larger company, it should yield even more key approvals in the field in the coming years.

Pfizer also recently made an up-front payment of $1.25 billion to China-based 3SBio for the rights to SSGJ-707, an investigational bispecific antibody, a portion of the oncology market that’s gaining traction these days. 3SBio will be eligible for commercial and regulatory milestone payments of up to $4.8 billion, not including royalties.

These moves should eventually pay off for Pfizer and strengthen its position in oncology. The drugmaker plans to have eight blockbuster cancer medicines on the market by 2030, up from its current five, while doubling its reach from the current 1 million patients it serves. Of course, Pfizer isn’t just a cancer play. The company’s extensive pipeline should enable it to launch products in other areas and ultimately get back on track.

While its shares have been lagging the market significantly, that could change in the next decade as financial results rebound thanks to its innovative efforts. Pfizer’s shares look especially attractive when considering its valuation. Its forward price-to-earnings (P/E) ratio is 8.7, much lower than the healthcare sector’s 15.8. From their current levels, Pfizer’s shares could go on to generate excellent returns through 2035.

2. Novo Nordisk

Novo Nordisk pioneered the market for weight management medicines. However, Eli Lilly seems to have taken the lead in that field, at least for now. Novo Nordisk has faced some clinical setbacks, leading to a poor performance over the trailing-12-month period. Can the company rebound and perform well in the next decade? In my view, it can, and the market may be significantly undervaluing its potential.

Its sales of Wegovy, one of the top-selling anti-obesity medications, continue to grow rapidly. Novo Nordisk recently requested approval from the U.S. Food and Drug Administration for oral semaglutide (the active ingredient in Wegovy). That’s good for patients who want a non-injected option, and helps counter Lilly’s up-and-coming oral GLP-1 medicine, orforglipron.

Elsewhere, Novo Nordisk recently started phase 3 studies for amycretin, a next-gen weight loss candidate. Amycretin is being investigated in both oral and subcutaneous formulations, and both are currently in late-stage clinical trials.

The company also enhanced its pipeline through licensing deals, including one with United Biotechnology, a subsidiary of the China-based company United Laboratories International Holdings, for UBT251. This potential anti-obesity medicine mimics the actions of three gut hormones: GLP-1, GIP, and glucagon. The transaction cost Novo Nordisk an up-front payment of $200 million and up to $1.8 billion in milestone payments.

Thanks to all these developments, Novo Nordisk should remain a leader in weight management in the next decade. Even though competition is mounting, no drugmaker not named Eli Lilly has a lineup or a pipeline as deep as Novo Nordisk’s. Furthermore, the Denmark-based pharmaceutical leader will also continue to dominate the diabetes market, as it has done for decades.

Novo Nordisk generates consistent revenue and earnings that typically grow faster than those of similarly-sized peers. Yet the stock’s forward P/E is 16.7, which is slightly above the industry average. In my view, that’s a bargain for a company that generates better-than-average results and has a deep pipeline in a fast-growing area — not to mention two of the world’s top 20 best-selling drugs, in Wegovy and Ozempic.

For investors willing to stay the course, Novo Nordisk’s future still looks incredibly bright.

Ethereum is trading just below the $2,500 mark, struggling to reclaim higher ground as bearish momentum picks up across the broader crypto market. After repeated failed attempts to break past resistance, ETH now sits under heavy selling pressure, raising concerns about a deeper correction. Bulls appear to be losing control as overall market sentiment weakens amid global economic uncertainty and the persistent weight of rising US Treasury yields. Some market participants are now bracing for a significant downturn if Ethereum fails to hold above key demand zones.

Related Reading

However, not everyone is turning bearish. Some prominent analysts maintain a highly bullish long-term view, arguing that Ethereum still has significant upside this cycle. According to Ted Pillows, Ethereum could reach $10,000 before the cycle ends. From his perspective, current price action represents a temporary dip rather than a trend reversal, and accumulating during weakness is the smarter move for long-term investors.

While short-term uncertainty dominates headlines, long-term conviction remains strong among Ethereum supporters who point to rising institutional interest, declining exchange supply, and the overall maturing of the Ethereum ecosystem as reasons to stay optimistic. For now, ETH’s position just under $2,500 sets the stage for a critical test in the days ahead.

Ethereum Analysts Eye Breakout Potential

Ethereum is currently testing a crucial support level at $2,500 after repeatedly reaching the $2,700 resistance over the past few weeks. This zone has proven difficult to break, but bulls are still holding the line. If ETH manages to reclaim the upper range and close above it, analysts believe it could ignite the altseason the market has been waiting for.

Despite Ethereum’s underperformance over the past year, marked by a lack of sustained momentum and significant selling pressure, the recent price action suggests a shift. Over the past few weeks, ETH has entered a more bullish phase, supported by increasing on-chain activity and stronger demand.

Some analysts remain firmly bullish. Ted Pillows, for example, has projected that Ethereum is headed above $10,000 this cycle. While short-term volatility may cause concern, long-term conviction remains strong. For many investors, the message is clear: embrace the dips, accumulate strategically, and avoid panic selling.

Technical sentiment across the board is turning cautiously optimistic. Market watchers point to Ethereum’s resilience at the $2,500 level as a sign of building strength. If this support holds and bulls step in with volume, the breakout above $2,700 could be swift and aggressive.

Related Reading

ETH Tests Key Support As Bulls Defend $2,500

Ethereum is currently trading around $2,488 after a 2% daily drop, showing continued weakness below the crucial $2,700 resistance zone. The chart highlights a clear consolidation range forming since early May, with ETH repeatedly failing to close above the 200-day SMA, currently around $2,680. This long-term moving average is acting as a significant barrier, preventing any breakout momentum from gaining traction.

Support remains at the lower boundary of the range near $2,470–$2,500, where buyers have consistently stepped in to absorb selling pressure. This area coincides with the 34-day EMA at $2,386 and the 100-day SMA just below current levels, forming a dense cluster of technical support.

However, volume has been declining, suggesting that neither bulls nor bears have clear control. If Ethereum loses the $2,470 level decisively, the next key area to watch lies near $2,300, where the 50-day SMA could act as a cushion.

Related Reading

Conversely, reclaiming $2,700 with strength could signal the beginning of a larger move to the upside. Until then, ETH remains stuck in a range, and traders will be watching closely for a decisive break—up or down to define Ethereum’s next major trend.

Featured image from Dall-E, chart from TradingView

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Ethereum continues to make waves in the broader cryptocurrency sector, even with its price falling below the $2,700 level once again as Thursday drew to a close. In recent weeks, ETH has shown notable bullish action, and several crypto analysts are highlighting its potential for a huge upward move toward higher levels in the short term.

Crucial Zone To Lead Ethereum To A New Peak

Given the current market weakness, Ethereum has lost some of its upward momentum after facing resistance at $2,800. Despite this brief pullback, ETH’s recent trend is pointing to a major rally, indicating an extension of the ongoing uptrend.

A seasoned crypto expert on the X platform, Trader Tardigrade, examining the price action, has forecasted a surge to a new all-time high. According to the technical analyst, Ethereum is currently navigating a critical technical zone that may serve as the impetus for one of its biggest rallies ever.

Examining the chart, this crucial zone is referred to as the Impulsive Waves zone. The expert is confident that ETH may be gearing up for a powerful surge to a new peak, as this zone has historically preceded massive upward breakout moves. 

Following a robust recovery in the last cycle, defined by a huge drop and a swift rebound, the expert claims that ETH is now entering the impulsive waves zone. Since the impulsive waves zone is known for its notable bullish influence on price, its recent emergence implies that ETH’s next major move might already be in motion.

With momentum building and Ethereum challenging key resistance levels, Trader Tardigrade foresees a substantial upward move to the $18,000 milestone, representing a nearly 700% rally from current price levels. The chart shows that the altcoin is likely to reach this untouched level by the second half of next year.

Is ETH Taking Over The Crypto Market?

Trader Tardigrade’s forecast could be backed by the fact that the market is slowly shifting towards an Ethereum season. A look at the ETH/BTC chart reveals that Ethereum is gaining bullish momentum as the pair rebounds from its monthly support level of 0.018.

Additionally, ETH’s price is forming a Bull Flag formation on the daily chart. A bull flag formation is a technical pattern that typically precedes a continued upward trend, suggesting that the altcoin’s bullish run is not yet over. When ETH breaks out from the bull flag pattern, the expert hints at a huge spike in price to the $4,000 mark. 

Crypto analysts like Javon Marks have predicted a sustained uptrend after hitting this key level last seen in December last year. As indicators align toward a rally, Javon Marks believes the next target for the altcoin is $4,811. The expert anticipates another +78% upside from this zone, pushing ETH to $8,500 and beyond.

Featured image from Getty Images, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Breaking The Long-Term SMA: Why This Level Matters

In a recent update on X, popular crypto analyst CryptoS6 pointed out that BONK is flashing signs of a significant technical shift. The price is currently testing the 200-day SMA at $0.0000238, an area widely regarded as a major trend-defining level. Reclaiming this zone would mark BONK’s first serious bullish reversal since early Q1, signaling that buyers are regaining control after months of sideways or bearish pressure. Such a shift in control could ignite renewed investor interest and set the stage for an extended rally.

What makes the setup even more interesting is the minimal resistance standing between the current price and the 0.5 Fibonacci retracement level at $0.0000348. According to CryptoS6, this area often becomes a magnet for breakout-driven momentum, creating room for swift upward moves. If BONK can firmly close above the 200-day SMA, the probability of a stronger rally increases dramatically, as traders are likely to pile in behind the move.

CryptoS6 didn’t hold back from making a bold projection either. He suggested that BONK’s chart is setting the stage for what could be a “God Candle” explosive move, a vertical price move that would rapidly push he token from $0.000025 to $0.00004. 

BONK 3-Way Confirmation: Volume, Trend & History Say ‘Go’

CryptoS6 firmly emphasized that a combination of growing volume, strong trend alignment, and striking historical pattern symmetry reinforces the case for a major breakout in BONK.  The recent surge in volume is not just noise; it reflects increasing market participation and suggests that accumulation is underway, often a precursor to a significant price move. Meanwhile, BONK’s price action is aligning with key moving averages, particularly as it eyes a reclaim of the 200-day SMA, a critical indicator of long-term trend shifts.

In conclusion, CryptoS6 described the setup as “clean,” meaning the chart offers a well-defined structure and reliable levels for both entry and risk management. With momentum continuously building and minimal resistance ahead, the risk/reward profile remains highly favorable.